ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

Adamson, Henney Chair Silicone Task Force

April 25, 1992

Acting NIH Director Says M.D. Anderson President John Mendelsohn Outlines 10-Point Plan For Cancer Research

February 20, 2009

Guest Editorial: As ACS Turns 100, Society President Calls For Tools To Finish the Fight Against Cancer

May 17, 2013

Moyniham Bill Will Direct HHS to Exempt Centers Recognized By NCI From Prospective Payment System

August 15, 1986

In Brief: Senate Subcommittee Recommends $1 .52 Billion

September 25, 1987

No Cancer Letter For Next Two Weeks

August 19, 1994